The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise

Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: A randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C)

(2008) Jørn Andersen et al.   ACTA ONCOLOGICA

Post-mastectomy radiotherapy in Denmark: From 2D to 3D treatment planning guidelines of The Danish Breast Cancer Cooperative Group

(2008) Mette S. Thomsen et al.   ACTA ONCOLOGICA

Sentinel node biopsy in breast cancer: Five years experience from Denmark

(2008) Peer Christiansen et al.   ACTA ONCOLOGICA

Recurrence pattern and prognosis in low-risk breast cancer patients – Data from the DBCG 89-A programme

(2008) Peer Christiansen et al.   ACTA ONCOLOGICA

Bisphosphonate treatment in primary breast cancer: Results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer

(2008) Bent Kristensen et al.   ACTA ONCOLOGICA

BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer

(2008) Mads Thomassen et al.   ACTA ONCOLOGICA

Postoperative radiotherapy in DBCG during 30 years. Techniques, indications and clinical radiobiological experience

(2008) Marie Overgaard et al.   ACTA ONCOLOGICA

Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol

(2008) Mogens Blichert-Toft et al.   ACTA ONCOLOGICA

Danish Breast Cancer Cooperative Group – DBCG: History, organization, and status of scientific achievements at 30-year anniversary

(2008) Mogens Blichert-Toft et al.   ACTA ONCOLOGICA

Adjuvant Chemotherapy With Sequential or Concurrent Anthracycline and Docetaxel: Breast International Group 02 98 Randomized Trial

(2008) P. Francis et al.   JNCI-Journal of the National Cancer Institute